Cholangiocarcinoma-Reference-Cited by-同舟云学术

Cholangiocarcinoma

Published:2021-06 Issue:3 Volume:113 Page:158-169
ISSN:1591-951X
Container-title:Pathologica
language:
Short-container-title:Pathologica

Author:

Sarcognato Samantha,Sacchi Diana,Fassan Matteo,Fabris Luca,Cadamuro Massimiliano,Zanus Giacomo,Cataldo Ivana,Capelli Paola,Baciorri Francesca,Cacciatore Matilde,Guido Maria

Publisher

Siapec Servizi Srl

Subject

Pathology and Forensic Medicine

Reference57 articles.

1. Banales JM, Marin JJG, Lamarca A, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol 2020;17:557-588. https://doi.org/10.1038/s41575-020-0310-z

2. Cholangiocarcinoma Working Group. Italian clinical practice guidelines on cholangiocarcinoma - Part I: Classification, diagnosis and staging. Dig Liver Dis 2020;52:1282-1293. https://doi.org/10.1016/j.dld.2020.06.045

3. WHO Classification of Tumors Editorial Board. Digestive system tumors. Fifth Edition. Lyon (France): International Agency for Research on Cancer 2019.

4. Banales JM, Cardinale V, Carpino G, et al. Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol 2016;13:261-280. https://doi.org/10.1038/nrgastro.2016.51

5. Rizvi S, Khan SA, Hallemeier CL, et al. Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev Clin Oncol 2018;15:95-111. https://doi.org/10.1038/nrclinonc.2017.157

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the crosstalk: circRNAs and the wnt signaling pathway in cancers of the digestive system;Non-coding RNA Research;2024-09

2. Hepatorenal Syndrome in the Setting of Intrahepatic Cholangiocarcinoma and Chronic Lymphedema: A Case Report;Cureus;2024-08-21

3. Ligustilide Inhibits the PI3K/AKT Signalling Pathway and Suppresses Cholangiocarcinoma Cell Proliferation, Migration, and Invasion;Recent Patents on Anti-Cancer Drug Discovery;2024-08-20

4. Lymphotoxin beta‐activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinoma;Liver International;2024-08-20

5. Efficacy and Safety of Robotic Surgery vs. Open Surgery for Hilar Cholangiocarcinoma: A Comprehensive Review;Cureus;2024-08-13